N'-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide, 95.0%, 25g

2-Fluoro-4-methylbenzonitirile, 97.0%, 1g

4-Methyl-1-[3-(trifluoromethyl)benzyl]-1H-pyrazol-5-amine, >95%, 1g

1,4-Dimethoxynaphthalene-2-carbaldehyde, 98%, 50mg

2-(4-Methoxy-phenoxy)-2-methyl-propionic acid, 95.0%, 1g

4-AMINO-3-FLUORO-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER, 95.0%, 1g

2-Amino-5-bromopyridine, 99.00%, 10g

6-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 1g

(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide, 98%, 250mg

Anti-GM3 Monoclonal Antibody (Culture Supernatant)0.2mL

3-Chloroisoquinolin-1(2H)-one, 98%, 1g

Placas de microtitulación inertGrade U-bottom estériles 40 uds.

(2R)-2-(2,4-DICHLOROPHENYL)PYRROLIDINE, 95.0%, 250mg